200 related articles for article (PubMed ID: 23071274)
1. Reduced rRNA expression and increased rDNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes.
Raval A; Sridhar KJ; Patel S; Turnbull BB; Greenberg PL; Mitchell BS
Blood; 2012 Dec; 120(24):4812-8. PubMed ID: 23071274
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Analysis of DNA Methylation in CD34+ Hematopoietic Progenitors in Myelodysplastic Syndrome.
Wong YF; Micklem CN; Taguchi M; Itonaga H; Sawayama Y; Imanishi D; Nishikawa S; Miyazaki Y; Jakt LM
Stem Cells Transl Med; 2014 Oct; 3(10):1188-98. PubMed ID: 25122688
[TBL] [Abstract][Full Text] [Related]
3. Aberrant promotor methylation in MDS hematopoietic cells during in vitro lineage specific differentiation is differently associated with DNMT isoforms.
Hopfer O; Komor M; Koehler IS; Freitag C; Schulze M; Hoelzer D; Thiel E; Hofmann WK
Leuk Res; 2009 Mar; 33(3):434-42. PubMed ID: 18829110
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine.
Giachelia M; D'Alò F; Fabiani E; Saulnier N; Di Ruscio A; Guidi F; Hohaus S; Voso MT; Leone G
Leuk Res; 2011 Apr; 35(4):465-71. PubMed ID: 20869114
[TBL] [Abstract][Full Text] [Related]
5. Reduced ribosomal RNA expression and unchanged ribosomal DNA promoter methylation in oral squamous cell carcinoma.
Ha S; Zhou H; Gautam M; Song Y; Wang C
Mol Genet Genomic Med; 2019 Jul; 7(7):e00783. PubMed ID: 31169368
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Ribosomal RNA in the Development of Human Cervical Cancer Is Associated with rDNA Promoter Hypomethylation.
Zhou H; Wang Y; Lv Q; Zhang J; Wang Q; Gao F; Hou H; Zhang H; Zhang W; Li L
PLoS One; 2016; 11(10):e0163340. PubMed ID: 27695092
[TBL] [Abstract][Full Text] [Related]
7. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation.
Hopfer O; Komor M; Koehler IS; Schulze M; Hoelzer D; Thiel E; Hofmann WK
Exp Hematol; 2007 May; 35(5):712-23. PubMed ID: 17577921
[TBL] [Abstract][Full Text] [Related]
9. Detection of differential mitotic cell age in bone marrow CD34(+) cells from patients with myelodysplastic syndrome and acute leukemia by analysis of an epigenetic molecular clock DNA signature.
Mossner M; Hopfer O; Nowak D; Baldus CD; Neumann U; Kmetsch A; Benlasfer O; John T; Perka C; Thiel E; Hofmann WK
Exp Hematol; 2010 Aug; 38(8):661-5. PubMed ID: 20399247
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the CpG island near SOX7 gene promoter is correlated with the poor prognosis of patients with myelodysplastic syndrome.
Fan R; Zhang LY; Wang H; Yang B; Han T; Zhao XL; Wang W; Wang XQ; Lin GW
Tohoku J Exp Med; 2012 Jun; 227(2):119-28. PubMed ID: 22706399
[TBL] [Abstract][Full Text] [Related]
11. CD34+ cells from patients with myelodysplastic syndrome present different p21 dependent premature senescence.
Xiao Y; Wang J; Song H; Zou P; Zhou D; Liu L
Leuk Res; 2013 Mar; 37(3):333-40. PubMed ID: 23219618
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
[TBL] [Abstract][Full Text] [Related]
13. 5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes.
Gawlitza AL; Speith J; Rinke J; Sajzew R; Müller EK; Schäfer V; Hochhaus A; Ernst T
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2835-2843. PubMed ID: 31506740
[TBL] [Abstract][Full Text] [Related]
14. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.
Jiang Y; Dunbar A; Gondek LP; Mohan S; Rataul M; O'Keefe C; Sekeres M; Saunthararajah Y; Maciejewski JP
Blood; 2009 Feb; 113(6):1315-25. PubMed ID: 18832655
[TBL] [Abstract][Full Text] [Related]
15. Expression of p15(ink4b) gene during megakaryocytic differentiation of normal and myelodysplastic hematopoietic progenitors.
Teofili L; Martini M; Di Mario A; Rutella S; Urbano R; Luongo M; Leone G; Larocca LM
Blood; 2001 Jul; 98(2):495-7. PubMed ID: 11435325
[TBL] [Abstract][Full Text] [Related]
16. Phagocytosis checkpoints on hematopoietic stem cells in patients with myelodysplastic syndromes.
Dong X; Han Y; Liu Y; Yang L; Niu H; Yan L; Liu C; Shao Z; Xing L; Wang H
Asia Pac J Clin Oncol; 2022 Apr; 18(2):e119-e128. PubMed ID: 34152084
[TBL] [Abstract][Full Text] [Related]
17. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells.
Wei Y; Chen R; Dimicoli S; Bueso-Ramos C; Neuberg D; Pierce S; Wang H; Yang H; Jia Y; Zheng H; Fang Z; Nguyen M; Ganan-Gomez I; Ebert B; Levine R; Kantarjian H; Garcia-Manero G
Leukemia; 2013 Nov; 27(11):2177-86. PubMed ID: 23538751
[TBL] [Abstract][Full Text] [Related]
18. Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation.
Ørskov AD; Treppendahl MB; Skovbo A; Holm MS; Friis LS; Hokland M; Grønbæk K
Oncotarget; 2015 Apr; 6(11):9612-26. PubMed ID: 25823822
[TBL] [Abstract][Full Text] [Related]
19. Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.
Ye Y; McDevitt MA; Guo M; Zhang W; Galm O; Gore SD; Karp JE; Maciejewski JP; Kowalski J; Tsai HL; Gondek LP; Tsai HC; Wang X; Hooker C; Smith BD; Carraway HE; Herman JG
Cancer Res; 2009 Nov; 69(21):8482-90. PubMed ID: 19826047
[TBL] [Abstract][Full Text] [Related]
20. Methylation of promoters of microRNAs and their host genes in myelodysplastic syndromes.
Erdogan B; Bosompem A; Peng D; Han L; Smith E; Kennedy ME; Alford CE; Wu H; Zhao Z; Mosse CA; El-Rifai W; Kim AS
Leuk Lymphoma; 2013 Dec; 54(12):2720-7. PubMed ID: 23547841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
